|
Aciont® To Present on VisulexTM Technologies at the 4th Ocular & Drug Discovery Conference -
01/10/2012
Kongnara Papankorn and Sarah Molokhia will present on behalf of Aciont Inc at the Global Technology Community’s 4th Ocular & Drug Discovery Conference, February 27-28, 2012, in Las Vegas, NV
|
| |
|
Aciont® to Present at the 13th Annual NIH SBIR/STTR Conference -
06/07/2011
Dr. Kongnara Papangkorn’s presentation is entitled,“Safety Aspects and Drug Delivery Performance of Visulex® Passive Delivery System”
|
| |
|
Aciont® to Present at ARVO 2011 Annual Meeting -
04/26/2011
Aciont’s poster “Importance of the Conjunctiva in Transscleral Iontophoresis” will be shown on May 3, 2011 at the meeting.
|
| |
|
Aciont® CEO to Present at IN3 West Medical Device Conference -
02/08/2011
John Higuchi will present on behalf of Aciont Inc at the IN3 West Medical Device Conference.
|
| |
|
Aciont® Awarded Two Qualifying Therapeutic Discovery Project Grants Totaling $489K -
11/04/2010
Aciont Inc. announced today that it has been awarded $488,958 to support two projects under the U.S. Government’s Qualifying Therapeutic Discovery Project (QTDP) program.
|
| |
|
University of Michigan Science Symposium Honoring Professor William I. Higuchi -
09/23/2010
|
| |
|
The NIH Awards Aciont® a Small Business Catalyst Award Grant Accelerating Innovative Research -
07/07/2010
Aciont is awarded a phase I SBIR $214K grant for the project titled "Novel Method for the Ocular Iontophoretic Delivery of Avastin® and Lucentis®"
|
| |
|
Aciont® To Present at ARVO 2010 Annual Meeting -
04/09/2010
|
| |
|
Aciont® Strengthens Management Team with Industry Leader in Ophthalmic Product Development -
04/02/2010
Balbir Brar brings 25 years of drug and device development experience to Aciont Inc.
|
| |
|
NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont® -
12/10/2009
The National Eye Institute (NEI) awarded a $2.18 million grant to Aciont Inc. to help fund its development of a non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis.
|
| |
|
Visulex Macromolecule Research Article -
05/04/2009
A peer reviewed journal published an article presenting research from
a study which used Aciont’s Visulex® ocular iontophoretic system in the non-invasive delivery of a macromolecule. The article presents the clearance, migration, and distribution data of GalbuminTM following ocular iontophoretic Visulex treatment.
|
| |
|
Aciont ARVO 2009 Presentations Article -
05/04/2009
|
| |
|
Tribute to William I. Higuchi in Journal of Pharmaceutical Sciences -
01/15/2008
Dr. Higuchi's contributions have significantly elevated the field of pharmaceutics. He has an impressive body of scientific work and a continuing legacy of his accomplishments.
|
| |
|
Aciont's Research Discussed in Two Recent Ophthalmic Publications -
11/21/2008
Aciont's research is published in Investigative Ophthalmology & Visual Science journal and Journal of Ocular Pharmacology and Therapeutics.
|
| |
|
NEI Awards Ocular Iontophoresis Research Grant to Aciont® Collaborators -
01/18/2007
Understanding of ocular pharmacokinetics and transport barriers of the eye would be a major step toward achieving a non-invasive drug delivery system to treat posterior segment of eye diseases.
|
| |
|
Aciont® Featured in Retina Today Article -
03/01/2007
Dr. Karl G. Csaky's article features new and exciting technologies in transscleral drug delivery.
|
| |
|
Aciont Announces SBIR Funding to Support the Development of its Back-of-the-Eye Therapy Technology - November 2004 -
11/09/2004
|
| |
|
Aciont's Visulex Technology Highlighted in Leading Drug Delivey Trade Magazine -
04/15/2004
Advancing iontophoresis for effective noninvasive back-of-the-eye therapeutics.
|
| |
|
Aciont® Featured in Digital IQ Article -
06/04/2003
|
| |
|
Aciont® Inc Awarded NIH Grant -
04/25/2002
Awarded a Phase-I Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH) for $100,000 payment based on the competitive merit of Aciont's proposal and technology.
|
| |
News Page
Executive Summary